局限期小细胞食管癌2种化疗方案的对比分析 |
| |
引用本文: | 杨森,张伟杰,蔡亚飞,王留兴. 局限期小细胞食管癌2种化疗方案的对比分析[J]. 肿瘤基础与临床, 2016, 0(2): 127-129. DOI: 10.3969/j.issn.1673-5412.2016.02.011 |
| |
作者姓名: | 杨森 张伟杰 蔡亚飞 王留兴 |
| |
作者单位: | 郑州大学第一附属医院肿瘤科,河南 郑州,450052 |
| |
摘 要: | 目的:对比分析依托泊苷联合顺铂(EP)与伊立替康联合顺铂(IP)2种化疗方案治疗局限期小细胞食管癌的疗效及预后。方法回顾性分析53例局限期小细胞食管癌患者的临床资料,53例均未出现远处转移,均采用放化疗联合治疗的模式,其中化疗方案的选择为 EP 方案28例,IP 方案25例。采用χ2检验分析2种方案的疾病控制率,Kaplan-Meier 法及 log rank 检验分析其生存时间。结果 EP 组的疾病控制率为78.6%,IP 组的疾病控制率为52.0%,差异有统计学意义(P <0.05)。EP 组中位生存期为9.5个月,IP组为8.0个月,差异有统计学意义(P <0.05)。结论 EP 方案联合放疗治疗局限期小细胞食管癌的近远期疗效均优于 IP 方案联合放疗。
|
关 键 词: | 局限期小细胞食管癌 放疗 化疗 |
Contrastive Analysis of Two Chemotherapy Regimens in the Treatment of Extensive-stage Small-cell Esophageal Cancer |
| |
Abstract: | Objective To contrastively analyze the efficacy and prognosis of two chemotherapy regimens(EP and IP)in the treatment of Limited-stage small-cell esophageal cancer. Methods The data of 53 Patients with Limited-stage small-cell esophageal cancer retrospectively analyzed. All the patients suffered from local advance-ment. They all adopted radiotherapy combined with chemotherapy. The 28 patients of them adopted EP regimen,and the other 25 patients adopted IP regimen. The Chi-square Test was used to analyze the disease control rates of the two kinds of chemotherapy regimens. The Kaplan-Meier and log rank methods were used to estimate the survival time. Results The disease control rate of the EP group was 78. 6% ,and was 52. 0% of the IP group(P < 0. 05).The median survival time of the EP group was 9. 5 months,and was 8. 0 months of the IP group(P < 0. 05). Con-clusion For limited-stage small-cell esophageal cancer,EP regimen combined with radiotherapy is better in the short-term and long-term efficacy than IP regimen combined with radiotherapy. |
| |
Keywords: | limited-stage small cell esophageal cancer radiotherapy chemotherapy |
本文献已被 万方数据 等数据库收录! |